OUR STUDIES – CLINICAL TRIALS2022-03-02T16:52:01+00:00

Clinical trials allow us to help patients of today and tomorrow. We currently have 12 active clinical trials, with 1 actively recruiting patients. This page will be updated as new studies are opened. If you do not see a study for the condition you are searching for, feel free to reach out to us at 855-554-6374 or recruitment@menterderm.com

Click here to learn more about clinical trials.

Clinical Trials


ATOPIC DERMATITIS: ASLAN004-0032022-03-29T20:32:51+00:00

ASLAN004-003: A randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial to evaluate the efficacy and safety of ASLAN004 in adult patients with moderate-to-severe atopic dermatitis.

Clinical trial for adults (age > 18) with at least a 6-month history of atopic dermatitis. In terms of severity, the trial requires a BSA involvement of >10% (and a minimum EASI score of 16). A subset of patients with prior dupixent exposure will be permitted to enter the study.

Study length: 16 weeks.

Clinicaltrials.gov NCT05158023

BSA is determined by measuring the number of handprints of involvement present. A handprint includes the palm and the fingers as shown in the image. 1-handprint is approximately equivalent to 1% of body surface area. In other words, if a study requires 10% – this will equate to 10-handprints.

REGISTRIES: Innovaderm ANB019-4012022-03-04T15:18:43+00:00

ANB019-401: An international, multicenter, prospective registry of patients with generalized pustular psoriasis (GPP).

Clinical trial for adults (age > 18) with clinically confirmed diagnosis of GPP.

Study length: 24 months.


  • Free medication

  • Innovative medications that would otherwise not be available to you*

  • Closely monitored by high quality, experienced medical staff

  • Satisfaction in contributing to the advancement of medical treatment

  • Compensation for participation

* No medication is guaranteed to be effective for everyone.

(No-longer Enrolling Patients)

PALMOPLANTAR PUSTULOSIS2021-05-21T18:08:35+00:00

BI 1368-0024


Abbvie M15-997

UCB PS0015

BMS IM011075

Arcutis ARC-154-309

HIDRADENITIS SUPPURATIVA2022-03-04T15:20:31+00:00

Novartis CAIN457M2301 & CAIN457M2301E1

ATOPIC DERMATITIS2022-03-04T15:17:56+00:00

Pfizer B7451015

AbbVie M16-045